Finnish cancer patient survives after paying €50,000 for foreign treatment – but warns not all have the same outcome

A Finnish man diagnosed with terminal liver cancer has lived for years after self-funding experimental treatment abroad, but warns others against false hope, reports Yle’s investigative program MOT.

Arttu Lampinen, from Helsinki, was told in late 2019 that his aggressive liver cancer was incurable and that he would be moved to palliative care. Instead, he researched alternative treatments online and arranged a series of procedures at a clinic in Frankfurt, Germany, at a total cost of around €50,000—funded through crowdfunding and personal savings.

The treatment, known as TACE (transarterial chemoembolization), involved injecting chemotherapy directly into his tumors before cutting off their blood supply. While the same method is available in Finland, Lampinen’s case was deemed inoperable domestically. After multiple sessions in Germany, his tumors shrank to 5 cm and were later destroyed via ablation. Medical records now confirm he has remained cancer-free for years.

Lampinen’s story has inspired many, but he admits some patients with advanced or metastatic cancers have contacted him seeking similar treatments—despite far lower chances of success. “I was lucky,” he told Yle. “The German treatments were perfect for my specific case.”

His experience reflects a growing but poorly documented trend. Finland’s Social Insurance Institution (Kela) processes only 30–40 annual reimbursement claims for overseas cancer treatments, though Lampinen suspects many more patients pay out of pocket to avoid bureaucratic delays. A 2023 survey by the Finnish Oncological Society found that 25 oncologists had patients who sought treatment abroad in the past two years, with 15 reporting severe complications—including two deaths—from procedures like TACE.

Most oncologists surveyed expressed concern over the safety of unregulated foreign treatments. While some patients, like Lampinen, achieve remarkable results, others—such as late actress Olga Temonen, who traveled to Germany and France for experimental therapies—ultimately succumb to their illness.

Lampinen now questions whether sharing his survival story has given false hope to those with less treatable cancers. “Not everyone’s case is like mine,” he cautioned.